Circulating CD4+CD25+ regulatory T cells in patients with pancreatic cancer.
Yamamoto T, Yanagimoto H, Satoi S, Toyokawa H, Hirooka S, Yamaki S, Yui R, Yamao J, Kim S, Kwon AH.
Yamamoto T, et al.
Pancreas. 2012 Apr;41(3):409-15. doi: 10.1097/MPA.0b013e3182373a66.
Pancreas. 2012.
PMID: 22158072
Their peripheral blood mononuclear cells were evaluated to determine the proportion of CD4CD25 (FoxP3) T cells, as a percentage of the total CD4 cells, by flow cytometric analysis. ...The immunological monitoring of Treg may be useful to predict the prognosis …
Their peripheral blood mononuclear cells were evaluated to determine the proportion of CD4CD25 (FoxP3) T cells, as a percentage of th …